| Gene symbol | ADGRE2 | Synonyms | CD312, CD97, EMR2, VBU | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.12 | dbXrefs | |
| Description | adhesion G protein-coupled receptor E2 | ||||
| Gene symbol | CLEC12A | Synonyms | CD371, CLL-1, CLL1, DCAL-2, MICL | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.31-p13.2 | dbXrefs | |
| Description | C-type lectin domain family 12 member A | ||||
| GTO ID | GTC3353 |
| Trial ID | NCT05748197 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | ADGRE2|CLEC12A |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ADCLEC.syn1 CAR T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Study of ADCLEC.syn1 CAR T Cells in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia |
| Year | 2024 |
| Country | United States |
| Company sponsor | Memorial Sloan Kettering Cancer Center |
| Other ID(s) | 23-002 |
| Cohort 1 | |||||||||||
|
|||||||||||